Sunday , August 18 2019
Home / taiwan / Takeda dengue fever candidate vaccine main phase 3 efficacy study reached the primary endpoint – HiNet News Community

Takeda dengue fever candidate vaccine main phase 3 efficacy study reached the primary endpoint – HiNet News Community




Key Phase 3 Efficacy Study of Takeda Dengue Fever Candidate Vaccine Reaches Primary Parameter HiNet News Community

The recent Phase 3 study showed that Takeda Tropical Fever Vaccine Candidate (TAK-003) effectively prevents tropical fever in children and adolescents living in tropical endemic countries. – The study found that the vaccine has been well tolerated so far …


Source link